# TheraSim

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/therasim

- Industry: Software
- Headquarters: Durham, US
- Website: www.therasim.com
- Total disclosed funding: $1.3M
- Latest round: Series B (Jan 7, 2010)
- Investors on record: 1

## About

TheraSim Inc. is a technology company specializing in innovative simulation solutions for healthcare professionals, enhancing training and education through advanced virtual environments.Founded in 2002 and based in Durham, US, TheraSim Inc. develops simulation technologies aimed at improving healthcare training. In July 2014, the company was sold to WebMD Health Corp, marking a significant pivot in its business strategy. The total amount raised by TheraSim Inc. is USD 1.25 mn from its latest funding round, Series B, with investors including Oxygen House. The company has engaged in two deals to date, with the most recent deal occurring on July 31, 2014.TheraSim Inc. offers advanced simulation solutions designed for healthcare training, focusing on creating realistic virtual environments. Their products cater to healthcare professionals, providing tools that enhance clinical skills through interactive simulations. This enables users to practice and refine their techniques in a risk-free setting, ultimately improving patient care outcomes.TheraSim Inc. generates revenue through the sale of its simulation solutions to healthcare institutions. The company's pricing structure is based on licensing agreements, enabling institutions to access their technology for training purposes. This direct-to-institution sales model is supported by ongoing partnerships with healthcare organizations, facilitating continuous engagement and revenue flow.After its acquisition by WebMD Health Corp, TheraSim Inc. aims to expand its product offerings and explore new market opportunities. They plan to launch new simulation modules designed specifically for telemedicine training by the end of 2025. Additionally, the company targets expansion into the European and Asian markets within the next two years, leveraging recent funding to enhance product development and marketing initiatives.

## Funding rounds

- Series B, Jan 7, 2010, $1.3M — Oxygen House

## Investors

- Oxygen House (https://capitalatlas.ai/funds/oxygen-house) — Series B